226 related articles for article (PubMed ID: 30468644)
21. Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin.
LeBeau AM; Brennen WN; Aggarwal S; Denmeade SR
Mol Cancer Ther; 2009 May; 8(5):1378-86. PubMed ID: 19417147
[TBL] [Abstract][Full Text] [Related]
22. A specific, transmembrane interface regulates fibroblast activation protein (FAP) homodimerization, trafficking and exopeptidase activity.
Wonganu B; Berger BW
Biochim Biophys Acta; 2016 Aug; 1858(8):1876-82. PubMed ID: 27155568
[TBL] [Abstract][Full Text] [Related]
23. Coupled expression of dipeptidyl peptidase-IV and fibroblast activation protein-α in transformed astrocytic cells.
Balaziova E; Busek P; Stremenova J; Sromova L; Krepela E; Lizcova L; Sedo A
Mol Cell Biochem; 2011 Aug; 354(1-2):283-9. PubMed ID: 21526345
[TBL] [Abstract][Full Text] [Related]
24. Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells.
Lai D; Ma L; Wang F
Int J Oncol; 2012 Aug; 41(2):541-50. PubMed ID: 22614695
[TBL] [Abstract][Full Text] [Related]
25. Bioluminescent Probe for Monitoring Endogenous Fibroblast Activation Protein-Alpha.
Lin Y; Ma Z; Li Z; Gao Y; Qin X; Zhang Z; Wang G; Du L; Li M
Anal Chem; 2019 Dec; 91(23):14873-14878. PubMed ID: 31670506
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
27. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
Wang RF; Zhang LH; Shan LH; Sun WG; Chai CC; Wu HM; Ibla JC; Wang LF; Liu JR
Exp Mol Pathol; 2013 Dec; 95(3):350-56. PubMed ID: 24422232
[TBL] [Abstract][Full Text] [Related]
28. FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor.
Ramirez-Montagut T; Blachere NE; Sviderskaya EV; Bennett DC; Rettig WJ; Garin-Chesa P; Houghton AN
Oncogene; 2004 Jul; 23(32):5435-46. PubMed ID: 15133496
[TBL] [Abstract][Full Text] [Related]
29. Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications.
Šimková A; Bušek P; Šedo A; Konvalinka J
Biochim Biophys Acta Proteins Proteom; 2020 Jul; 1868(7):140409. PubMed ID: 32171757
[TBL] [Abstract][Full Text] [Related]
30. Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy.
Kelly T
Drug Resist Updat; 2005; 8(1-2):51-8. PubMed ID: 15939342
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21.
Dunshee DR; Bainbridge TW; Kljavin NM; Zavala-Solorio J; Schroeder AC; Chan R; Corpuz R; Wong M; Zhou W; Deshmukh G; Ly J; Sutherlin DP; Ernst JA; Sonoda J
J Biol Chem; 2016 Mar; 291(11):5986-5996. PubMed ID: 26797127
[TBL] [Abstract][Full Text] [Related]
32. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
Akinboye ES; Brennen WN; Rosen DM; Bakare O; Denmeade SR
Prostate; 2016 Jun; 76(8):703-14. PubMed ID: 26835873
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast activation protein and chronic liver disease.
Wang XM; Yao TW; Nadvi NA; Osborne B; McCaughan GW; Gorrell MD
Front Biosci; 2008 Jan; 13():3168-80. PubMed ID: 17981786
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.
Busek P; Balaziova E; Matrasova I; Hilser M; Tomas R; Syrucek M; Zemanova Z; Krepela E; Belacek J; Sedo A
Tumour Biol; 2016 Oct; 37(10):13961-13971. PubMed ID: 27492457
[TBL] [Abstract][Full Text] [Related]
35. Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance from Lungs in Mice.
Fan MH; Zhu Q; Li HH; Ra HJ; Majumdar S; Gulick DL; Jerome JA; Madsen DH; Christofidou-Solomidou M; Speicher DW; Bachovchin WW; Feghali-Bostwick C; Puré E
J Biol Chem; 2016 Apr; 291(15):8070-89. PubMed ID: 26663085
[TBL] [Abstract][Full Text] [Related]
36. Using substrate specificity of antiplasmin-cleaving enzyme for fibroblast activation protein inhibitor design.
Lee KN; Jackson KW; Terzyan S; Christiansen VJ; McKee PA
Biochemistry; 2009 Jun; 48(23):5149-58. PubMed ID: 19402713
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts.
Ospelt C; Mertens JC; Jüngel A; Brentano F; Maciejewska-Rodriguez H; Huber LC; Hemmatazad H; Wüest T; Knuth A; Gay RE; Michel BA; Gay S; Renner C; Bauer S
Arthritis Rheum; 2010 May; 62(5):1224-35. PubMed ID: 20155839
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies.
Kelly T; Huang Y; Simms AE; Mazur A
Int Rev Cell Mol Biol; 2012; 297():83-116. PubMed ID: 22608558
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast activation protein: A potential therapeutic target in cancer.
Liu R; Li H; Liu L; Yu J; Ren X
Cancer Biol Ther; 2012 Feb; 13(3):123-9. PubMed ID: 22236832
[TBL] [Abstract][Full Text] [Related]
40. Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection.
Levy MT; McCaughan GW; Marinos G; Gorrell MD
Liver; 2002 Apr; 22(2):93-101. PubMed ID: 12028401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
